Statistics

Total Visits

Views
BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)17

Select a period of time:

Number of views in the range

Views
BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)10

Views

Views
November 20231
December 20231
January 20241
February 20241
March 20242
April 20241
May 20243
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
 

Top cities views

Views
Boardman2
Ashburn2
Chicago1